Q2 2010

Filed Aug 17, 2010 · 10-Q · 45 days after period end · 0001193125-10-190790

Q2 2010 · 10-Q

Revenue

$2.03M

no prior Q2 2009 on file

Net Income

-$303.53K

no prior Q2 2009 on file

EPS Diluted

-$0.01

no prior Q2 2009 on file

Gross Profit$775,689—

Operating Income

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jul 3, 2010 · filed Aug 17, 2010 · 45 d after period end

Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR